[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.124.106. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
June 2, 1934

Annual Reprint of the Reports of the Council on Pharmacy and Chemistry of the American Medical Association for 1933 with the Comments That Have Appeared in The Journal

Author Affiliations
 

Cloth. Price, $1. Pp. 188. Chicago: American Medical Association, 1933.

JAMA. 1934;102(22):1875. doi:10.1001/jama.1934.02750220053028

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

A feature of marked current interest in this volume is the preliminary report on alpha-dinitrophenol, the new drug for acceleration of cellular metabolism. The Council voices a warning on the dangers attending the use of this drug; this warning has been increasingly justified in reports of fatalities since the appearance of the Council's report in July of last year. Other preliminary reports which make this volume one of the most interesting issued by the Council in recent years are those on Dilaudid, a new narcotic drug related to morphine; Fuadin, a new antimony compound for use in the treatment of bilharziasis and granuloma inguinale, and Hippuran, a new product for intravenous and oral urography.

The comprehensive and definitive special report on estrogenic substances furnishes a much needed review of the present status of such products in gynecologic therapy. The Council insists on the doctrine that basic laboratory investigation of these

First Page Preview View Large
First page PDF preview
First page PDF preview
×